Annis Gardner Whiting Capital Advisors’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$338K Buy
3,970
+1,017
+34% +$90.6K 0.05% 237
2025
Q4
$233K Sell
2,953
-80
-3% -$6.27K 0.04% 271
2025
Q3
$242K Sell
3,033
-157
-5% -$13.4K 0.05% 252
2025
Q2
$290K Buy
3,190
+12
+0.4% +$1.09K 0.1% 176
2025
Q1
$298K Buy
3,178
+15
+0.5% +$1.34K 0.13% 152
2024
Q4
$288K Buy
3,163
+44
+1% +$4.2K 0.08% 180
2024
Q3
$324K Hold
3,119
0.09% 174
2024
Q2
$303K Buy
3,119
+1,014
+48% +$93.5K 0.09% 182
2024
Q1
$190K Buy
2,105
+116
+6% +$9.83K 0.07% 190
2023
Q4
$159K Buy
1,989
+3
+0.2% +$226 0.07% 172
2023
Q3
$141K Buy
+1,986
New +$148K 0.08% 169

Other funds holding CL

Annis Gardner Whiting Capital Advisors's CL Position: Q1 2026 in Review

Annis Gardner Whiting Capital Advisors increased its Colgate-Palmolive (CL) stake by 34% in Q1 2026, buying an estimated $90.6K and bringing the position to 3,970 shares worth $338K. The position accounts for 0.05% of the portfolio, ranked #237.

Annis Gardner Whiting Capital Advisors first reported a position in CL in Q3 2023 and has held it in 11 quarters since. 1,947 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Annis Gardner Whiting Capital Advisors held 3,970 shares of Colgate-Palmolive worth $338K as of Q1 2026.
  • Annis Gardner Whiting Capital Advisors bought 1,017 Colgate-Palmolive shares in Q1 2026, an estimated $90.6K.
  • Colgate-Palmolive made up 0.05% of Annis Gardner Whiting Capital Advisors's portfolio in Q1 2026, its #237 holding.
  • Annis Gardner Whiting Capital Advisors first reported a position in Colgate-Palmolive in Q3 2023 and has held it in 11 quarters since.
  • 1,947 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Annis Gardner Whiting Capital Advisors's 13F filing for Q1 2026, filed 6 May 2026.